fbpx

SPRAVATO Treatment for Treatment-Resistant Depression in Griffin, GA

Offered at GloFusion Health’s Mental Health Services & Urgent Care

If you’re struggling with treatment-resistant depression or major depressive disorder with suicidal thoughts and haven’t found relief through traditional oral antidepressants, SPRAVATO® (esketamine) nasal spray may be a breakthrough option for you. GloFusion Health is proud to offer certified SPRAVATO® treatment services at our Griffin, GA clinic under the guidance of experienced mental health professionals.

What is Spravato Nasal Spray

SPRAVATO® (esketamine) is a prescription nasal spray derived from ketamine, FDA-approved to treat:
  • Treatment-Resistant Depression (TRD) in adults
  • Major Depressive Disorder (MDD) with acute suicidal ideation or behavior
Unlike oral antidepressants that may take weeks to show effect, SPRAVATO® can provide rapid symptom relief, especially during mental health crises. It is always used alongside an oral antidepressant and administered under clinical supervision in a certified healthcare setting.
Spravato
Spravato

SPRAVATO Dosing Guide: What to Expect

SPRAVATO® treatment follows a structured dosing plan across two phases: Induction and Maintenance.

1. Induction Phase (Weeks 1–4):

  • Twice-weekly treatments
  • 56 mg or 84 mg dose per session
  • Helps assess individual tolerance and rapid symptom relief

2. Maintenance Phase (Week 5 and beyond):

  • Once-weekly doses (Weeks 5–8)
  • Every 2 weeks or as clinically needed thereafter
  • Dose may be 56 mg or 84 mg depending on therapeutic response
Your provider will adjust the schedule based on symptom improvement, tolerability, and long-term goals.
Spravato

How Is SPRAVATO Administered?

SPRAVATO® is self-administered nasal spray given under medical supervision in our clinic:
  • You’ll sit comfortably in a treatment chair in a private room.
  • Our clinician will guide you in using the nasal spray (2-3 devices depending on dose).
  • You’ll then be monitored for 2 hours post-administration to watch for side effects like dissociation, sedation, or blood pressure changes.
  • You must arrange transportation after treatment – driving is not allowed on treatment days.

Important Safety Information About SPRAVATO

What is the most important information I should know about SPRAVATO®?

SPRAVATO® can cause serious side effects, including:
  • Sedation, dissociation, and respiratory depression. You may feel sleepy, faint, dizzy, anxious, or disconnected from your body or surroundings.
  • Tell your healthcare provider immediately if you feel like you cannot stay awake or if you are going to pass out.
  • Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO®.

Abuse and Misuse

  • SPRAVATO® carries a risk for abuse and dependence.
  • Inform your provider if you have a history of substance use disorders.

SPRAVATO® REMS Program

  • SPRAVATO® is only available through the Risk Evaluation and Mitigation Strategy (REMS) Program.
  • GloFusion Health is a certified REMS treatment center.

Suicidal Thoughts and Behaviors

  • Antidepressants may increase suicidal thoughts in patients aged 24 and under.
  • Depression and serious mental illnesses are leading causes of suicidal behavior.
  • You and your family should monitor any changes in mood, behavior, or thoughts.
  • Contact your provider or emergency services if symptoms worsen.
Symptoms to watch for:
  • New or worsening depression
  • Thoughts of suicide or self-harm
  • Anxiety, panic attacks, restlessness
  • Aggression or unusual mood changes

How to Use SPRAVATO Nasal Spray

  • Do not blow your nose prior to use.
  • Insert spray into one nostril, press plunger.
  • Repeat in the second nostril. Wait 5 minutes between sprays if using multiple devices.
  • Sit upright for 5 minutes post-use.
A trained professional at GloFusion Health will guide and assist you during every session.

Is SPRAVATO Right for You?

SPRAVATO® is not suitable for:
  • Individuals with a history of aneurysms or intracerebral bleeding
  • Those with substance use disorders (evaluated case-by-case)
  • Pregnant or breastfeeding individuals
  • Patients under 18 years old
A comprehensive psychiatric evaluation will determine eligibility.

SPRAVATO Patient Resources at GloFusion Health

We provide a full range of resources to support patients throughout the treatment journey:

SPRAVATO Dosing Guide

A detailed outline of dosage adjustments across treatment phases (induction, optimization, and maintenance). Helps patients understand their journey and what to expect.

SPRAVATO Referral Form

Streamlined form for healthcare providers to refer eligible patients to our REMS-certified clinic.

SPRAVATO Treatment Guide

Comprehensive educational guide that covers benefits, expectations, potential risks, and frequently asked questions.

Ready to Start?

If you or a loved one are battling treatment-resistant depression or suicidal thoughts and seeking fast-acting relief, SPRAVATO® at GloFusion Health in Griffin, GA may offer the hope you need.
Contact us today to speak with a certified provider, schedule your evaluation, or request a referral packet.
 
We're here to guide your path to healing—safely, compassionately, and effectively.